Danaher
The firm said preliminary core Q4 2024 revenues are expected to be flat, exceeding prior expectations, while its China business has stabilized and will recover.
People in the News at Danaher, QuidelOrtho, Myriad Genetics, Hologic, Pacific Biosciences, More
Recently posted executive and academic appointments, promotions, and departures in omics and molecular diagnostics.
In Brief This Week: Inocras, Sysmex Inostics, Danaher, Abbott, Genesupport, GeninCode, More
News items for the week of Dec. 9, 2024.
Cepheid Tuberculosis Assay Receives WHO Prequalification
The WHO noted that Cepheid's test is the first test for tuberculosis and antibiotic susceptibility testing that meets the prequalification standards.
Wolfe Research Upgrades Danaher to Outperform
The upgrade is based on the firm's improving growth, more reasonable valuations, and its ability to deploy capital.
Oct 22, 2024
Aug 19, 2024
Danaher Acquires Swiss Informatics Firm Genedata
Jul 23, 2024
Apr 23, 2024